Manipulating the Genome of Human Embryos: Some Unforeseen Effects
By Craig Holdrege,
The Nature Institute
| 06. 22. 2015
Untitled Document
In recent years scientists have developed powerful tools to create specific breaks in DNA sequences. They can then either repair those breaks or introduce new DNA into the sequence at the site of the break. These are called genome editing techniques. Two main techniques at present are the CRISPR-Cas9 system and zinc-finger nucleases. In principle, researchers can modify any part of the genome. They have achieved intended modifications in experiments with human and animal cells and also with mouse embryos. But the specific alterations do not always occur and there are also unintended effects.
The techniques are not as precise as they are sometimes made out to be, so there is every reason for caution in their application, especially in connection with the manipulation of human cells or human embryos. But over and beyond technical issues is the pressing ethical concern: should researchers cross the line into genetically manipulating human embryos?
Knowing that scientists in China were performing these experiments, two groups of researchers and others published comments in Science and Nature in March 2015 warning about...
Related Articles
By Courtney Withers and Daryna Zadvirna, ABC News | 12.03.2025
Same-sex couples, single people, transgender and intersex West Australians will be able to access assisted reproductive technology (ART) and surrogacy, almost a decade after reforms were first promised.
The landmark legislation, which removes the requirement for people to demonstrate medical...
By Rachel Hall, The Guardian | 11.20.2025
Couples are needlessly going through IVF because male infertility is under-researched, with the NHS too often failing to diagnose treatable causes, leading experts have said.
Poor understanding among GPs and a lack of specialists and NHS testing means male infertility...
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...